4.0 Article

Operational Definitions and Algorithms for Excessive Sleepiness in the General Population Implications for DSM-5 Nosology

Journal

ARCHIVES OF GENERAL PSYCHIATRY
Volume 69, Issue 1, Pages 71-79

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archgenpsychiatry.2011.1240

Keywords

-

Categories

Funding

  1. National Institutes of Health [R01NS044199]
  2. Cephalon, Inc.

Ask authors/readers for more resources

Context: Excessive sleepiness (ES) is poorly defined in epidemiologic studies, although its adverse implications for safety, health, and optimal social and vocational functioning have been extensively reported. Objective: To determine the importance of ES definition, measurement, and prevalence in the general population, together with its coexisting conditions. Design: Cross-sectional telephone study. Participants: A total of 15 929 individuals representative of the adult general population of 15 states in the United States. Main Outcome Measures: Interviews were carried out using Sleep-EVAL, a knowledge-based expert system for use in epidemiologic studies, focusing on sleep, as well as physical and mental disorders, according to classification in DSM-IV and the second edition of the International Classification of Sleep Disorders. The interviews elicited information on ES, naps, frequency, duration, impairment, and distress associated with ES symptoms. Results: Excessive sleepiness was reported by 27.8% (95% CI, 27.1%-28.5%) of the sample. Excessive sleepiness with associated symptoms was found in 15.6% of the participants (95% CI, 15.0%-16.2%). Adding an ES frequency of at least 3 times per week for at least 3 months despite normal sleep duration dropped the prevalence to 4.7% of the sample (95% CI, 4.4%-5.0%). The proportion of individuals having social or professional impairment and psychological distress increased with the frequency of ES symptoms during the week and within the same day. In multivariate models, the number of ES episodes per day and severity of ES were identified as the best predictors for impairment/distress. Prevalence of hypersomnia disorder was 1.5% of the participants (95% CI, 1.3%-1.7%). The most common coexisting conditions were mood and substance use disorders. Conclusions: Excessive sleepiness is an important problem in the US population, even when using restrictive criteria to define it. Hypersomnia disorder is more prevalent than previously estimated. Excessive sleepiness has to be recognized and given attention by public health authorities, scientists, and clinicians.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Longitudinal study to assess antidepressant treatment patterns and outcomes in individuals with depression in the general population

Maurice M. Ohayon, Maggie McCue, Andrew Krystal, Katherine J. Selzler, Lambros Chrones, Debra Lawrence, Marie-Lise Cote

Summary: This study aimed to understand the evolution of depression and treatment satisfaction over a 3-year period in primary care settings. Results showed a high prevalence of depression and low rates of remission. Dissatisfaction with treatment, frequent switching of antidepressants, and changing care providers were identified as challenges that need to be addressed in future research.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Article Clinical Neurology

Sleep symptoms are essential features of long-COVID - Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II)

Ilona Merikanto, Yves Dauvilliers, Frances Chung, Yun Kwok Wing, Luigi De Gennaro, Brigitte Holzinger, Bjorn Bjorvatn, Charles M. Morin, Thomas Penzel, Christian Benedict, Adrijana Koscec Bjelajac, Ngan Yin Chan, Colin A. Espie, Harald Hrubos-Strom, Yuichi Inoue, Maria Korman, Anne-Marie Landtblom, Damien Leger, Kentaro Matsui, Sergio Mota-Rolim, Michael R. Nadorff, Giuseppe Plazzi, Catia Reis, Juliana Yordanova, Markku Partinen

Summary: An international survey study reveals that post-acute sequelae of COVID-19 symptoms are more prevalent among severe cases and long-lasting sleep problems are at the core of these symptoms. Understanding the importance of sleep-related symptoms has clinical relevance in diagnosing and treating long-COVID.

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

Home nocturnal infrared video to record non-rapid eye movement sleep parasomnias

Regis Lopez, Lucie Barateau, Sofiene Chenini, Anna Laura Rassu, Yves Dauvilliers

Summary: This study evaluated the feasibility, acceptability, and usefulness of home nocturnal infrared video recording in assessing the frequency and complexity of non-rapid eye movement sleep parasomnias in adults, as well as monitoring treatment response.

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

Rapid eye movement sleep duration during the multiple sleep latency test to diagnose hypocretin-deficient narcolepsy

Regis Lopez, Lucie Barateau, Anna Laura Rassu, Elisa Evangelista, Sofiene Chenini, Sabine Scholz, Isabelle Jaussent, Yves Dauvilliers

Summary: The study aims to evaluate alternative measures of the multiple sleep latency test (MSLT) for identifying hypocretin-deficiency in patients with hypersomnolence, including narcolepsy patients. The results show that compared to the current neurophysiological standard criteria, alternative MSLT measures are more effective in identifying hypocretin-deficient patients with hypersomnolence and narcolepsy. Daytime REM sleep duration is highlighted as a relevant neurophysiological biomarker of hypocretin-deficiency, which can be used in clinical and research settings.

SLEEP (2023)

Article Clinical Neurology

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder

Dieter Kunz, Yves Dauvilliers, Heike Benes, Diego Garcia-Borreguero, Giuseppe Plazzi, Dalma Seboek Kinter, Preciosa Coloma, Magdalene Rausch, Mouna Sassi-Sayadi, Stephen Thein

Summary: In this 40-week extension study, Daridorexant was found to be safe and well-tolerated for long-term treatment of insomnia disorder. It improved sleep and daytime functioning, with the most pronounced effects observed with the 50 mg dose.

CNS DRUGS (2023)

Article Clinical Neurology

Brain-derived neurotrophic factor (BDNF) variants and promoter I methylation are associated with prolonged nocturnal awakenings in older adults

Marie-Laure Ancelin, Isabelle Jaussent, Karen Ritchie, Alain Besset, Joanne Ryan, Yves Dauvilliers

Summary: This study examines the association between BDNF variants and promoter I methylation with sleep disturbances in older adults. The results show that wake time after sleep onset (WASO) is associated with four SNPs in participants not taking psychotropic drugs, while the associations are either not significant or in the reverse direction in participants taking drugs. Higher BDNF methylation levels are found in participants with long WASO, and this varies depending on psychotropic drug use.

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

Cognitive strategies to improve symptoms of restless legs syndrome

Sofiene Chenini, Lucie Barateau, Lily Guiraud, Marie-Lou Rollin, Regis Lopez, Isabelle Jaussent, Severine Beziat, Yves Dauvilliers

Summary: One-third of patients with restless legs syndrome reported a decrease in symptoms during cognitive activities, and this improvement was confirmed during a sustained cognitive task.

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial

Yves Dauvilliers, Thomas Roth, Richard Bogan, Michael J. Thorpy, Anne Marie Morse, Asim Roy, Jordan Dubow, Jennifer Gudeman

Summary: This study evaluated the efficacy of extended-release once-nightly sodium oxybate (ON-SXB; FT218) compared to placebo for daytime sleepiness and disrupted nighttime sleep in narcolepsy type 1 (NT1) and 2 (NT2). The results showed significant improvements in sleep latency, sleep quality, nocturnal arousals, and daytime sleepiness for both NT1 and NT2 subgroups treated with ON-SXB compared to placebo.

SLEEP (2023)

Article Clinical Neurology

The effect of brain-derived neurotrophic factor Val66Met polymorphism on adolescent activity and rest rhythms, circadian preferences and attentional performance

Luisa da Costa Lopes, Dalva Lucia Rollemberg Poyares, Sergio Tufik, Sophia La Banca de Oliveira, Julia Ribeiro da Silva Vallim, Vanessa Kiyomi Ota, Maria Isabel Melaragno, Maurice Ohayon, Claudia Berlim de Mello

Summary: This study aimed to evaluate the effect of the BDNF Val66Met polymorphism on the performance of adolescents in attentional tests, circadian preferences, and activity-rest rhythm. The results showed that the time that the students attended school had an impact on all types of attention, regardless of chronotype. The presence of the BDNF Val66Met polymorphism was only associated with alternate attention performance.

SLEEP MEDICINE (2023)

Article Clinical Neurology

Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem

Tobias Di Marco, Thomas E. Scammell, Michael Meinel, Dalma Seboek Kinter, Alexandre N. Datta, Gary Zammit, Yves Dauvilliers

Summary: The study aimed to explore the effect of daridorexant, a dual orexin receptor antagonist, on nighttime wake bouts and their correlation with daytime functioning. Results showed that daridorexant reduced the number and duration of long wake bouts during the night compared with placebo, corresponding with improved daytime functioning.

CNS DRUGS (2023)

Review Immunology

The immunopathogenesis of narcolepsy type 1

Roland S. Liblau, Daniela Latorre, Birgitte R. Kornum, Yves Dauvilliers, Emmanuel J. Mignot

Summary: Narcolepsy type 1 (NT1) is a chronic sleep disorder caused by the loss of certain hypothalamic neurons. It is suspected to have an immune-mediated basis, supported by genetic evidence and increased incidence after vaccination. The search for antigens recognized by pathogenic T cell response in NT1 is ongoing, and animal models provide insights into the roles of autoreactive T cells.

NATURE REVIEWS IMMUNOLOGY (2023)

Meeting Abstract Clinical Neurology

PREVALENCE AND INCIDENCE OF NARCOLEPSY IN THE US GENERAL POPULATION

Maurice Ohayon, Marie-Lise Cote

SLEEP (2023)

Meeting Abstract Clinical Neurology

NATURAL EVOLUTION OF INSOMNIA IN MAJOR DEPRESSIVE DISORDERS

Maurice Ohayon, Marie-Lise Cote

SLEEP (2023)

Meeting Abstract Clinical Neurology

IMPROVEMENT IN SLEEP LATENCY WITH FT218 (ONCE-NIGHTLY SODIUM OXYBATE): ANALYSIS FROM THE PHASE 3 REST-ON CLINICAL TRIAL

Michael Thorpy, Colin Shapiro, Clete Kushida, Maurice Ohayon, Jordan Dubow, Jennifer Gudeman

SLEEP (2023)

Meeting Abstract Clinical Neurology

THE ROLE OF HYPERSOMNOLENCE IN DEPRESSION: RESULTS FROM A LONGITUDINAL STUDY OF THE AMERICAN GENERAL POPULATION

Maurice Ohayon, Amir Pakpour, Marie Lise Cote

SLEEP (2022)

No Data Available